Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cardiff Oncology, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 117 | 2 | 104 | −11 |
| Shares | 24.6M | 3.06K | 18.7M | −5.88M (−23.9%) |
| Value | $39.7M | $4.95K | $24.2M | −$15.5M (−39.1%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Cardiff Oncology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 272,786 | $354.0K | 0.00% |
| X-Square Capital, LLC | 205,700 | $267.0K | 0.07% |
| Marshall Wace, LLP | 162,214 | $210.9K | 0.00% |
| Qube Research & Technologies Ltd | 125,550 | $163.2K | 0.00% |
| Ieq Capital, LLC | 44,630 | $58.0K | 0.00% |
| Point72 Asset Management, L.P. | 28,385 | $36.9K | 0.00% |
| HSBC Holdings PLC | 28,996 | $36.8K | 0.00% |
| Quadrature Capital Ltd | 26,867 | $34.9K | 0.00% |
| Engineers Gate Manager LP | 24,994 | $32.5K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 22,388 | $29.1K | 0.00% |
| Axq Capital, LP | 13,110 | $17.0K | 0.00% |
| Mercer Global Advisors Inc | 12,755 | $16.6K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 12,095 | $16.1K | 0.00% |
| Colony Group, LLC | 10,144 | $13.2K | 0.00% |
| Golden State Wealth Management, LLC | 7,050 | $9.16K | 0.00% |
| Parkside Financial Bank & Trust | 385 | $501 | 0.00% |
| Fortitude Family Office, LLC | 379 | $493 | 0.00% |
| SJS Investment Consulting Inc. | 63 | $82 | 0.00% |
| Parallel Advisors, LLC | 35 | $46 | 0.00% |
| Front Row Advisors LLC | 1 | $1 | 0.00% |
Sold out (31)
Institutions that held Cardiff Oncology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
Not filed for Q2 2026 yet (2)
Institutions that held Cardiff Oncology, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 3,040 | $4.92K |
| Sunbelt Securities, Inc. | 17 | $28 |